Literature DB >> 8642318

Negative selection of human germinal center B cells by prolonged BCR cross-linking.

L Galibert1, N Burdin, C Barthélémy, G Meffre, I Durand, E Garcia, P Garrone, F Rousset, J Banchereau, Y J Liu.   

Abstract

The antigen receptors on T and B lymphocytes can transduce both agonist and antagonist signals leading either to activation/survival or anergy/death. The outcome of B lymphocyte antigen receptor (BCR) triggering depends upon multiple parameters which include (a) antigen concentration and valency, (b) duration of BCR occupancy, (c) receptor affinity, and (d) B cell differentiation stages. Herein, using anti-immunoglobulin kappa and lambda light chain antibodies, we analyzed the response of human naive, germinal center (GC) or memory B cells to BCR cross-linking regardless of heavy chain Ig isotype or intrinsic BCR specificity. We show that after CD40-activation, anti-BCR (kappa + gamma) can elicit an intracellular calcium flux on both GC and non-GC cells. However, prolonged BCR cross-linking induces death of CD40-activated GC B cells but enhances proliferation of naive or memory cells. Anti-kappa antibody only kills kappa + GC B cells without affecting surrounding gamma + GC B cells, thus demonstrating that BCR-mediated killing of GC B lymphocytes is a direct effect that does not involve a paracrine mechanism. BCR-mediated killing of CD40-activated GC B cells could be partially antagonized by the addition of IL-4. Moreover, in the presence of IL-4, prestimulation through CD40 could prevent subsequent anti-Ig-mediated cell death, suggesting a specific role of this combination in selection of GC B cells. This report provides evidence that in human, susceptibility to BCR killing is regulated along peripheral B cell differentiation pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8642318      PMCID: PMC2192588          DOI: 10.1084/jem.183.5.2075

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  48 in total

1.  Proliferation of resting B cells is modulated by CR2 and CR1.

Authors:  J D Fingeroth; M E Heath; D M Ambrosino
Journal:  Immunol Lett       Date:  1989-06-15       Impact factor: 3.685

2.  Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas.

Authors:  T Brunner; R J Mogil; D LaFace; N J Yoo; A Mahboubi; F Echeverri; S J Martin; W R Force; D H Lynch; C F Ware
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

3.  Mechanism of antigen-driven selection in germinal centres.

Authors:  Y J Liu; D E Joshua; G T Williams; C A Smith; J Gordon; I C MacLennan
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

4.  A novel in vivo follicular dendritic cell-dependent iccosome-mediated mechanism for delivery of antigen to antigen-processing cells.

Authors:  A K Szakal; M H Kosco; J G Tew
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

5.  Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes.

Authors:  R H Carter; M O Spycher; Y C Ng; R Hoffman; D T Fearon
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

6.  Activation of human B lymphocytes through CD40 and interleukin 4.

Authors:  A Vallé; C E Zuber; T Defrance; O Djossou; M De Rie; J Banchereau
Journal:  Eur J Immunol       Date:  1989-08       Impact factor: 5.532

7.  Flow cytometric analysis of the Hermes homing-associated antigen on human lymphocyte subsets.

Authors:  J de los Toyos; S Jalkanen; E C Butcher
Journal:  Blood       Date:  1989-08-01       Impact factor: 22.113

8.  Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation.

Authors:  E C Butcher; R V Rouse; R L Coffman; C N Nottenburg; R R Hardy; I L Weissman
Journal:  J Immunol       Date:  1982-12       Impact factor: 5.422

9.  Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.

Authors:  D W Scott; D Livnat; J Whitin; S B Dillon; R Snyderman; C A Pennell
Journal:  J Mol Cell Immunol       Date:  1987

10.  In vivo obtained antigen presented by germinal center B cells to T cells in vitro.

Authors:  M H Kosco; A K Szakal; J G Tew
Journal:  J Immunol       Date:  1988-01-15       Impact factor: 5.422

View more
  12 in total

Review 1.  Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.

Authors:  Laura I Salazar-Fontana; Dharmesh D Desai; Tarik A Khan; Renuka C Pillutla; Sandra Prior; Radha Ramakrishnan; Jennifer Schneider; Alexandra Joseph
Journal:  AAPS J       Date:  2017-01-12       Impact factor: 4.009

2.  Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling via the IL-4 receptor complex in human neonatal B cells.

Authors:  Cuixia Tian; Grace K Kron; Kevin M Dischert; James N Higginbotham; James E Crowe
Journal:  Immunology       Date:  2006-06-08       Impact factor: 7.397

Review 3.  Cellular choreography in the germinal center: new visions from in vivo imaging.

Authors:  Anja E Hauser; Steven M Kerfoot; Ann M Haberman
Journal:  Semin Immunopathol       Date:  2010-07-09       Impact factor: 9.623

4.  Dendritic cells and follicular dendritic cells express a novel ligand for CD38 which influences their maturation and antibody responses.

Authors:  Michelle N Wykes; Lynette Beattie; Gordon G Macpherson; Derek N Hart
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

5.  Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice.

Authors:  Djemel Aït-Azzouzene; Dwight H Kono; Rosana Gonzalez-Quintial; Louise J McHeyzer-Williams; Min Lim; Dilki Wickramarachchi; Tobias Gerdes; Amanda L Gavin; Patrick Skog; Michael G McHeyzer-Williams; David Nemazee; Argyrios N Theofilopoulos
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

6.  Expression of immunoglobulin receptors with distinctive features indicating antigen selection by marginal zone B cells from human spleen.

Authors:  Monica Colombo; Giovanna Cutrona; Daniele Reverberi; Silvia Bruno; Fabio Ghiotto; Claudya Tenca; Kostas Stamatopoulos; Anastasia Hadzidimitriou; Jenny Ceccarelli; Sandra Salvi; Simona Boccardo; Maria Grazia Calevo; Amleto De Santanna; Mauro Truini; Franco Fais; Manlio Ferrarini
Journal:  Mol Med       Date:  2013-09-17       Impact factor: 6.354

7.  CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production.

Authors:  Matthew P Bernard; Richard P Phipps
Journal:  Clin Immunol       Date:  2007-08-28       Impact factor: 3.969

Review 8.  Manipulating B cell homeostasis: a key component in the advancement of targeted strategies.

Authors:  Laura S Treml; William J Quinn; John F Treml; Jean L Scholz; Michael P Cancro
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

9.  B lymphocyte chemotaxis regulated in association with microanatomic localization, differentiation state, and B cell receptor engagement.

Authors:  C C Bleul; J L Schultze; T A Springer
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

10.  Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells.

Authors:  Götz R A Ehrhardt; Joyce T Hsu; Lanier Gartland; Chuen-Miin Leu; Shuangyin Zhang; Randall S Davis; Max D Cooper
Journal:  J Exp Med       Date:  2005-09-12       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.